Picard Medical is trading at $4.78, down -5.91%, with no verified company-specific announcement, earnings release, or analyst action identified for September 21, 2026.
- The latest company filing located was its August 19 second-quarter results release.
- The decline follows two consecutive sessions of losses, including -9.29% on September 18, while major U.S. indexes are higher pre-market.
- This suggests an unclear, stock-specific move rather than broad market weakness.